Woman Man | et 99 years
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Chimiothérapie
Extract
Phase II study to evaluate the efficacy and tolerability of fulvestrant 250mg, 250mg plus 250mg loading regimen and 500mg in postmenopausal women with ER +ve advanced breast cancer progressing or relapsing after previous endocrine therapy.
Scientific Abstract
en cours d'intégration;